This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beijing Foreland Biopharma Co., Ltd.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Zhuolin Dai: Innovator in Medical Chemistry
Introduction
Zhuolin Dai is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical chemistry, particularly in the development of compounds that can aid in immune suppression and the treatment of various inflammatory diseases.
Latest Patents
Zhuolin Dai holds a patent for a "Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof." This invention provides a novel preparation method and application for a heterocyclic group contained amino-methanol derivative and its salts. The compounds developed through this patent are intended for use in preparing medicines that address organ transplant rejection and immune-mediated inflammatory diseases, such as multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Career Highlights
Zhuolin Dai is associated with Beijing Foreland Biopharma Co., Ltd., where he continues to work on innovative solutions in the medical field. His research focuses on creating effective treatments that can improve patient outcomes in critical health conditions.
Collaborations
Zhuolin Dai collaborates with notable colleagues, including Xingmin Zhang and Ensi Wang, who contribute to his research efforts and the advancement of their shared goals in medical innovation.
Conclusion
Zhuolin Dai's work exemplifies the impact of innovative research in the medical field. His contributions through patents and collaborations are paving the way for new treatments that can significantly improve the quality of life for patients facing serious health challenges.